相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Radiologic progression of glioblastoma under therapy-an exploratory analysis of AVAglio
Martha Nowosielski et al.
NEURO-ONCOLOGY (2018)
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
J. N. Jakobsen et al.
JOURNAL OF NEURO-ONCOLOGY (2018)
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients
David Cachia et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Influence of Bevacizumab on Blood Brain Barrier Permeability and O-(2-18F-Fluoroethyl)-L-Tyrosine Uptake in Rat Gliomas
Carina Stegmayr et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
Advances in neuro-oncology imaging
Karl-Josef Langen et al.
NATURE REVIEWS NEUROLOGY (2017)
Lomustine and Bevacizumab in Progressive Glioblastoma
Wolfgang Wick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy
Norbert Galldiks et al.
NEUROIMAGE-CLINICAL (2017)
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
Nathalie L. Albert et al.
NEURO-ONCOLOGY (2016)
Amino Acid PET - An Imaging Option to Identify Treatment Response, Posttherapeutic Effects, and Tumor Recurrence?
Norbert Galldiks et al.
FRONTIERS IN NEUROLOGY (2016)
From the clinician's point of view - What is the status quo of positron emission tomography in patients with brain tumors?
Norbert Galldiks et al.
NEURO-ONCOLOGY (2015)
Treatment Response Evaluation Using 18F-FDOPA PET in Patients with Recurrent Malignant Glioma on Bevacizumab Therapy
Johannes Schwarzenberg et al.
CLINICAL CANCER RESEARCH (2014)
Comparison of the Amino Acid Tracers 18F-FET and 18F-DOPA in High-Grade Glioma Patients
Constantin Lapa et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Single-agent bevacizumab or lomustine versus a combination of bevacizumab plus lomustine in patients with recurrent glioblastoma (BELOB trial): a randomised controlled phase 2 trial
Walter Taal et al.
LANCET ONCOLOGY (2014)
Combined PET/MR imaging in neurology: MR-based attenuation correction implies a strong spatial bias when ignoring bone
Flemming Littrup Andersen et al.
NEUROIMAGE (2014)
Progression types after antiangiogenic therapy are related to outcome in recurrent glioblastoma
Martha Nowosielski et al.
NEUROLOGY (2014)
Response assessment of bevacizumab in patients with recurrent malignant glioma using [F-18]Fluoroethyl-l-tyrosine PET in comparison to MRI
Norbert Galldiks et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Earlier Diagnosis of Progressive Disease during Bevacizumab Treatment Using O-(2-18F-Fluorethyl)-L-Tyrosine Positron Emission Tomography in Comparison with Magnetic Resonance Imaging
Norbert Galldiks et al.
MOLECULAR IMAGING (2013)
Antiangiogenic therapy for patients with glioblastoma: current challenges in imaging and future directions
Manmeet S. Ahluwalia et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
O-(2-18F-Fluoroethyl)-L-Tyrosine PET Predicts Failure of Antiangiogenic Treatment in Patients with Recurrent High-Grade Glioma
Markus Hutterer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
PET and SPECT Studies of Brian Tumors with Radiolabeled Amino Acids
K. -J Langen et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2011)
High resolution BrainPET combined with simultaneous MRI
H. Herzog et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2011)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas
Frederic G. Dhermain et al.
LANCET NEUROLOGY (2010)
Bevacizumab plus irinotecan in recurrent glioblastoma multiforme
James J. Vredenburgh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
D Pauleit et al.
BRAIN (2005)
Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine
K Hamacher et al.
APPLIED RADIATION AND ISOTOPES (2002)
Malignant gliomas: MR imaging spectrum of radiation therapy- and chemotherapy-induced necrosis of the brain after treatment
AJ Kumar et al.
RADIOLOGY (2000)